An investigation for investors in NASDAQ:GILD shares over potential securities laws violations by Gilead Sciences and certain of its directors and officers in connection certain financial statements was announced.
Investors who purchased shares of Gilead Sciences, Inc. (NASDAQ:GILD) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Gilead Sciences, Inc. (NASDAQ:GILD) concerning whether a series of statements by Gilead Sciences, regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Gilead Sciences, Inc. reported that its annual Total Revenue rose from $24.89 billion in 2014 to over $32.63 billion in 2015 and that its Net Income increased from over $12.1 billion in 2014 to over $18.1 billion in 2015.
On May 27, 2016,it was reported that Gilead Sciences, Inc had received a subpoena from the U.S. Attorney for the District of Massachusetts, initially disclosed in the Company’s 10-Q for the quarter ended March 31, 2016, seeking documents related to the Company’s relationship with certain nonprofits that provide financial assistance to patients.
Shares of Gilead Sciences, Inc. (NASDAQ:GILD) closed on June 7, 2016, at $87.50 per share.
Those who purchased NASDAQ:GILD shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com